Marker Therapeutics, Inc.
Ticker: MRKR
| Insider | Title |
|---|---|
| Anna Szymanska | Vice President, Quality |
| Anthony H. Kim | Chief Financial Officer |
| David Laskow-pooley | Director |
| Eliot M Lurier | Interim CFO |
| Frederick Gerald Wasserman | Director |
| Gerald Garrett | Vice President, Clinical Ops. |
| John Robert Wilson | Director |
| Juan Vera | President and CEO, Director |
| Katharine Knobil | Director |
| Michael Loiacono | Chief Accounting Officer |
| Mythili Koneru | Chief Medical Officer |
| Nadia Agopyan | SVP, Regulatory Affairs |
| Norman David Eansor | Director |
| Peter L. Hoang | President and CEO, Director |
| Steve Elms | Director |
| Tsvetelina P Hoang | VP, Research and Development |